Suvoda Partners with Bolt Business to Enhance Patient Travel
Suvoda Partners with Bolt Business to Enhance Patient Travel
Recently, Suvoda, a leading global clinical trial technology company, has entered a pivotal partnership with Bolt Business, a prominent mobility firm in Europe. This strategic collaboration aims to provide a more efficient and cost-effective means of transportation for clinical trial participants navigating various trials within the European Union.
Improving Access to Clinical Trials
The collaboration will allow patients involved in clinical trials to avail themselves of Bolt rides, eliminating any out-of-pocket expenses for travelers. Will Wing, the Director of Product, Travel at Suvoda, articulated the necessity of this partnership, stating that patients facing complex health challenges already endure enough without the added stress of unreliable transportation. Many participants in clinical trials often struggle to maintain their appointments due to logistical issues.
Enhancing Patient Retention
By mitigating travel obstacles, Suvoda’s partnership with Bolt Business supports improved patient retention rates. This crucial aspect is vital as sponsors and sites seek to ensure the consistent participation of patients throughout the trial process. Offering reliable transportation solutions ensures that participants can maintain their health journeys without added stress, thus promoting a smooth clinical trial experience.
A Shared Commitment to Participants
Liam James, Account Manager at Bolt Business, emphasized the collaborative nature of this partnership, noting that both organizations are dedicated to removing barriers faced by trial participants. By enabling flexible transportation options across EU markets, the partnership streamlines access for patients without compromising quality or safety.
Investing in Global Clinical Trials
This partnership marks yet another step in Suvoda’s commitment to enhancing global travel services for clinical trial participants. The company has demonstrated a strong track record and currently supports over 8,400 sites involved in more than 2,000 studies across over 50 countries.
Comprehensive Support and Innovation
Suvoda’s travel solutions incorporate high-touch delivery models, featuring over 90 dedicated Concierge Coordinators who specialize in assisting trial participants. These coordinators offer personalized support, particularly for those involved in rare or ultra-rare disease trials, which require meticulous attention to detail. This approach has contributed to a notable satisfaction rating of 90% among sites globally.
The Road Ahead
Continuing its innovative trajectory, Suvoda completed its merger with Greenphire, a significant player in the field of clinical trial financial management and patient support. This integration merges advanced technologies under the Suvoda Platform, thereby delivering comprehensive software solutions that address critical clinical trial challenges effectively.
About Suvoda
Suvoda is dedicated to empowering clinical trial sponsors and contract research organizations (CROs) through its real-time experience platform. The platform aims to facilitate confident decisions from sponsors and enable sites and patients to engage in a proactive manner. Suvoda’s interconnected software solutions, coupled with industry-leading services and support, allow trial studies to progress efficiently amidst time-sensitive situations. Headquartered near Philadelphia, Suvoda operates offices in various parts of the world, maintaining high customer satisfaction scores that exceed industry norms.
Contact Information
For additional inquiries, interested parties can reach Robin Abadía, Director of External Communications, through the provided contacts. Suvoda welcomes any questions regarding their services or this recent partnership.
Frequently Asked Questions
What is the purpose of the Suvoda and Bolt Business partnership?
The partnership aims to enhance transportation options for clinical trial participants, ensuring they can access trials without additional financial burdens.
How will this partnership improve patient retention in clinical trials?
By providing reliable and cost-free transportation, patients are more likely to remain enrolled in trials, which is critical for successful outcomes.
What services does Suvoda offer for clinical trials?
Suvoda provides comprehensive travel services along with support for trial management, patient engagement, and financial management.
How many clinical trial sites does Suvoda currently support?
Suvoda supports over 8,400 sites engaged in more than 2,000 studies across various countries, enhancing their reach and efficiency in clinical trials.
What is the significance of the merger between Suvoda and Greenphire?
The merger combines advanced technologies and expertise in clinical trial management, improving service delivery and enhancing participant support.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.